Work

Cetuximab is Associated With Excessive Toxicity When Combined With Bevacizumab Plus mFOLFOX6 in Metastatic Colorectal Carcinoma

Year: 2010

Type: article

Study design: Clinical Trial

Source: Clinical Colorectal Cancer

DOI: 10.3816/ccc.2010.n.042

Authors: Allyson J. Ocean, Blase Polite, Paul Christos, Lisa Horvath, Anne Hamilton, Daniel Matulich, Helen X. Chen, Joseph A. Sparano, Hedy L. Kindler

Institutions: Cornell University, University of Chicago, The University of Sydney, Albert Einstein College of Medicine, Montefiore Medical Center, National Institutes of Health, National Cancer Institute

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Eli Lilly and Company, Sanofi, National Institutes of Health, Genentech, National Cancer Institute

Awards: Early Therapeutics Development with Phase II Emphasis, G1964418830, G3424222379, G371985182, Early Therapeutics Development with Phase II Emphasis, G671773936

OpenAlex ID: W2067841013

FWCI: 0.142

Cites: 21

Cited by: 8

Related to: 10